396 MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor, in combination with docetaxel: clinical and preclinical experience

✍ Scribed by P. O'Dwyer; K. Papadopoulos; R. Amaravadi; K. Harlacker; M. Beeram; M. Drouin; M. Mehran; J. Besterman; C. Maroun; A. Patnaik

• Book ID: 119603079
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 45 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)72103-0